Nuprobe, inc.

NuProbe, Inc. is a leading biotechnology company that specializes in developing ultrasensitive and highly-multiplexed assays for low-frequency variant detection on NGS and PCR platforms. The company's innovative technology has revolutionized the field of molecular diagnostics by enabling accurate and reliable detection of genetic mutations at an unprecedented level of sensitivity.

NuProbe's proprietary technology is based on a unique combination of molecular biology, chemistry, and bioinformatics. The company's assays are designed to detect low-frequency variants with high specificity and sensitivity, making them ideal for applications such as cancer diagnosis, liquid biopsy, prenatal testing, infectious disease detection, and more.

One of the key advantages of NuProbe's technology is its ability to multiplex thousands of targets in a single reaction. This means that researchers can detect multiple mutations simultaneously without sacrificing accuracy or sensitivity. This makes NuProbe's assays ideal for large-scale screening programs where time and cost are critical factors.

NuProbe has also developed a range of products that are compatible with both NGS and PCR platforms. These include probes for targeted sequencing, library preparation kits for NGS workflows, as well as custom assay development services tailored to meet the specific needs of individual researchers or organizations.

The company has established partnerships with leading academic institutions, research organizations, clinical laboratories as well as pharmaceutical companies around the world. Its products have been used in numerous studies published in top-tier scientific journals such as Nature Genetics, Science Translational Medicine among others.

NuProbe was founded by Drs David Zhang (CEO) and Peng Yin (CSO) in 2016 with the aim to develop innovative solutions that address some of the most pressing challenges facing modern medicine today. Since then it has grown rapidly into one of the most respected names in molecular diagnostics industry thanks to its cutting-edge technology platform combined with exceptional customer service.

In conclusion NuProbe Inc., is an innovative biotechnology company dedicated to developing ultrasensitive assays for low-frequency variant detection on NGS and PCR platforms. Its proprietary technology has revolutionized the field of molecular diagnostics by enabling accurate and reliable detection of genetic mutations at an unprecedented level of sensitivity. With its range of products, custom assay development services, and partnerships with leading academic institutions, research organizations, clinical laboratories as well as pharmaceutical companies around the world NuProbe is poised to continue its growth trajectory in the years to come.